Philips convenes the 2019 Annual General Meeting of Shareholders
March 25 2019 - 3:00AM
Philips convenes the 2019 Annual General Meeting of Shareholders
March 25, 2019
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA) today convenes the 2019 Annual General
Meeting of Shareholders (AGM) and publishes the agenda with
explanatory notes. The agenda includes proposals to re-appoint
Frans van Houten as President/CEO and member of the Board of
Management, and Abhijit Bhattacharya as member of the Board of
Management fulfilling the role of CFO. The AGM agenda also includes
proposals to re-appoint David Pyott as a member of the Supervisory
Board with immediate effect, and to appoint Elizabeth Doherty as a
member of the Supervisory Board per August 1, 2019.
Ms Doherty is a senior finance executive with 30 years of
international finance experience in large multi-national
organizations across a range of industries. She has extensive
operational experience in international consumer and retail
businesses, specifically with branding, marketing and online sales.
Her expertise will be invaluable in view of Philips’ transformation
into a customer-centric solutions company focused on health
technology across the personal health and professional healthcare
domains.
As previously reported, Heino von Prondzynski, whose third term
will expire at the end of the AGM 2019, and Jackson Tai, whose
second term will expire, will step down as members of the
Supervisory Board.
Furthermore, the agenda includes the proposal to re-appoint
Ernst & Young Accountants LLP as the external auditor of
Philips. The AGM will be held at the Hotel Okura Amsterdam
(Ferdinand Bolstraat 333, Amsterdam) on Thursday May 9, 2019,
beginning at 14:00 hours CET.
Click here to view the complete agenda with explanatory notes,
the Annual Report 2018 (which was published on February 26, 2019),
the binding nominations, as well as all other documents related to
the AGM, including the new services agreements between the company
and each of Mr Van Houten and Mr Bhattacharya.
For further information, please contact:
Steve KlinkPhilips Group Press OfficeTel.: +31 6 10888824E-mail:
steve.klink@philips.com
Ksenija GonciarenkoPhilips Investor RelationsTel.: +31 20 59
77055E-mail: ksenija.gonciarenko@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips' health technology portfolio generated 2018
sales of EUR 18.1 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024